NEW YORK--(BUSINESS WIRE)--Medidata Solutions (NASDAQ: MDSO), a leading global provider of SaaS-based clinical development solutions, today announced that Purdue Pharma L.P. has selected Medidata Designer® as its enterprise-wide clinical study design optimization solution. Using Medidata Designer to author protocols for all new studies, Purdue has been able to strengthen operating procedures compliance and adherence to standards for protocol development and now has the tools in place to optimize study design by eliminating efforts associated with collection of unnecessary data.
